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Background. A recent study has shown that pure neural stem cells can be derived from embryonic stem (ES) cells and primary
brain tissue. In the presence of fibroblast growth factor 2 (FGF2) and epidermal growth factor (EGF), this population can be
continuously expanded in adherent conditions. In analogy to continuously self-renewing ES cells, these cells were termed ‘NS’
cells (Conti et al., PLoS Biol 3: e283, 2005). While NS cells have been shown to readily generate neurons and astrocytes, their
differentiation into oligodendrocytes has remained enigmatic, raising concerns as to whether they truly represent tripotential
neural stem cells. Methodology/Principal Findings. Here we provide evidence that NS cells are indeed tripotent. Upon
proliferation with FGF2, platelet-derived growth factor (PDGF) and forskolin, followed by differentiation in the presence of
thyroid hormone (T3) and ascorbic acid NS cells efficiently generate oligodendrocytes (,20%) alongside astrocytes (,40%)
and neurons (,10%). Mature oligodendroglial differentiation was confirmed by transplantation data showing that NS cell-
derived oligodendrocytes ensheath host axons in the brain of myelin-deficient rats. Conclusions/Significance. In addition to
delineating NS cells as a potential donor source for myelin repair, our data strongly support the view that these adherently
expandable cells represent bona fide tripotential neural stem cells.
Citation: Glaser T, Pollard SM, Smith A, Bru ¨stle O (2007) Tripotential Differentiation of Adherently Expandable Neural Stem (NS) Cells. PLoS ONE 2(3):
e298. doi:10.1371/journal.pone.0000298
INTRODUCTION
Neural stem cells are defined as clonogenic cells capable of self-
renewal and multipotent differentiation into the three principle cell
types of the CNS – neurons, astrocytes and oligodendrocytes.
They have been isolated from the fetal [1–6] and adult [7–14]
mammalian central nervous system (CNS). Another source of
neural stem cells are embryonic stem (ES) cells [15,16]. In the
adult brain, the subventricular zone (SVZ) of the lateral ventricles,
which generates olfactory bulb neurons, and the subgranular zone
(SGZ) of the hippocampus are the primary regions where
neurogenesis occurs [8,11,17,18]. Fetal and adult neural stem
cells have been shown to exhibit properties of radial glia and
astrocytes, respectively [19–24]. Neural stem cells have been
frequently propagated as neurospheres, multicellular aggregates
which proliferate in the presence of epidermal growth factor (EGF)
and/or fibroblast growth factor 2 (FGF2) [7,25]. Upon plating and
differentiation, they give rise to neurons, astrocytes and oligoden-
drocytes. However, neurospheres are limited in that they contain
a mixture of neural stem cells and more differentiated progenitor
cells in a common extracellular matrix [26–28]. Clonal analyses of
dissociated single sphere cells revealed that only a small percentage
(3–4%) of the cells within neurospheres are truly multipotent stem
cells [29,30].
Survival, proliferation and differentiation of stem cells appear to
be regulated by both cell-autonomous and environmental signals
[31,32]. Intrinsic regulators include proteins involved in asym-
metric cell division, nuclear factors controlling gene expression
and epigenetic modifications. In vivo, the external signals that
control stem cell fate collectively make up the stem cell ‘niche’
[33,34]. This niche has powerful effects on their resident stem cells
in maintaining a balance of quiescence, self-renewal, and cell fate
commitment. Signals generated from the niche include a wide
range of secreted factors, cell-cell interactions mediated by integral
membrane proteins and the extracellular matrix. Neurosphere
cultures are supposed to provide some of these niche signals that
may be relevant for neural stem cell maintenance, survival and
proliferation.
In a recent study Conti et al. have reported on niche
independent symmetrical self renewal of adherently growing
neural stem cells derived from primary CNS tissue and ES cells
[35]. These cells are diploid and clonogenic and undergo sustained
symmetrical self-renewal divisions in response to FGF2 and EGF
independent from any specific cellular niche. In analogy to self-
renewing pluripotent ES cells, they were termed ‘NS’ cells. NS
cells were found to express Pax6, GLAST and BLBP mRNAs and
are immunopositive for nestin, RC2, vimentin, 3CB2, SSEA1/
Lex1, Pax6 and prominin. These markers are considered to be
diagnostic for neurogenic radial glia, suggesting that NS cells are
closely related to a radial glia lineage [36]. NS cells also express the
neural precursor markers Sox2, Sox3, and Emx2, and the bHLH
transcription factors Olig2 and Mash1.
Upon exposure to serum or BMP4, NS cells differentiate into
astrocytes. Culture without EGF followed by FGF2 withdrawal
gives rise to cells with immunochemical and electrophysiological
properties of mature neurons. Importantly, even after prolonged
expansion, NS cells maintain their potential to differentiate
efficiently into neurons and astrocytes in vitro and upon
transplantation into the adult brain. However, the culture
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cells into oligodendrocytes.
In the past, growth and differentiation factors suitable for the
proliferation and differentiation of oligodendocyte progenitors
have been successfully used to derive myelinating oligodendrocytes
from ES cells [37,38]. We set out to explore whether these
paradigms support tripotential differentiation of NS cells including
the oligodendroglial lineage.
RESULTS AND DISCUSSION
The clonally derived NS cell line NS-5 generated from mouse ES
cells was propagated and passaged according to Conti et al. [35]
(Fig. 1A). To promote oligodendroglial differentiation cells were
cultured on polyornithine/laminin coated dishes in medium
containing N2 supplement plus FGF2, platelet-derived growth
factor (PDGF) and forskolin, a growth factor combination known
to enhance oligodendrocyte progenitor proliferation. After 4 days
this condition resulted in a population of small cells with
condensed cell bodies and short processes (Fig. 1B). Terminal
differentiation was initiated by a 4-day-growth factor withdrawal
in the presence of the thyroid hormone tri-iodothyronine (T3) and
ascorbic acid [38]. Under these conditions, NS cells efficiently
differentiated into oligodendrocytes, astrocytes and neurons
(Fig. 1C,D). Quantitative results of the antigenic marker
expression are summarized in Fig. 2A. Differentiated cultures
contained 2164% O4-positive oligodendrocytes (Fig. 2B),
4569% of the cells expressed the astrocytic marker GFAP
(Fig. 2C,D) and a fraction of 1163% was found to be positive
for the neuronal antigen ß-III tubulin/TUJ1 (Fig. 2C). Oligo-
dendroglial differentiation could also be demonstrated by labelling
with the RIP antibody, which recognizes 29,39-cyclic nucleotide 39-
phosphodiesterase (CNPase) in oligodendrocytes [39] (Fig. 2D).
Furthermore, cells with ramified processes and characteristic
oligodendroglial morphology expressed myelin proteolipid protein
(PLP) (Fig. 2E). Similar data have been obtained with NS cells
derived from foetal mouse brain (Sandra G. Lopez & Steven M.
Pollard, data not shown).
To study whether NS cells can generate oligodendrocytes in
vivo, we transplanted them into the brain of 2- to 3-day-old
myelin-deficient (md) rats. This mutant carries a point mutation in
the PLP gene, which results in severe dysmyelination and
oligodendrocyte cell death [40]. Due to the lack of endogenous
myelin formation and the absence of PLP expression in md rats,
donor-derived internodes can be easily detected by mere PLP
immunolabeling [37,38]. Following injection into the cerebral
hemispheres, donor cells propagated in the presence of FGF2,
PDGF and forskolin migrated into the host tissue where they
adopted highly ramified morphologies with parallel PLP-positive
processes typical of mylinating oligodendrocytes (Fig. 2F–H).
Two weeks after transplantation, donor-derived PLP-positive
myelin internodes were found in a variety of host brain regions
including septum (Fig. 2F), striatum and corpus callosum
(Fig. 2G,H).
Taken together, these data demonstrate that the differentiation
spectrum of NS cells is not restricted to neurons and astrocytes but
extends also to oligodendrocytes. This multipotential differentia-
tion capacity of ES-cell-derived NS cells confirms their status of
a tripotent stem cell. Previous studies have shown that tissue- and
ES cell-derived oligodendrocyte progenitors can be efficiently
proliferated in the presence of FGF2 and PDGF [37,41].
Furthermore, T3 and ascorbic acid are known to promote the
differentiation and survival of oligodendrocytes [6,38]. Thus, the
mechanisms regulating primary oligodendrocyte progenitor pro-
liferation and differentiation appear to be preserved in NS cells.
Importantly, the ability for oligodendroglial differentiation is
maintained after transplantation. Our data show that NS cells
proliferated in FGF2 and PDGF can migrate into the recipient
brain, integrate with host cells and ensheath host axons in
a myelin-deficient environment. These observations not only
support the ability of NS cells to generate mature oligodendrocytes
but also depict them as a potential donor source for myelinating
transplants.
MATERIALS AND METHODS
Culture and differentiation of NS cells
ES cell-derived NS cells were generated and cultured as previously
described [35]. All experiments were done on the clonal cell line
NS-5. For oligodendroglial differentiation cells were plated on
polyornithin/laminin-coated dishes, and the NS cell expansion
medium, which is composed of NS-A medium (Euroclone, Pero,
Italy) plus N2 supplement (Invitrogen; Karlsruhe, Germany), was
replaced by DMEM/F12 supplemented with N2 (N2 medium).
Cells were proliferated in the presence of FGF2 (10 ng/ml; R&D
Systems, Wiesbaden, Germany), PDGF (10 ng/ml; R&D Systems)
and forskolin (10 mM; Sigma, Steinheim, Germany) for 4 days to
support a glial precursor stage. Differentiation was induced by a 4-
day-growth factor withdrawal in the presence of 3,3,5-tri-
iodothyronine (T3; 30 ng/ml; Sigma) and ascorbic acid (AA;
200 mM; Sigma).
Figure 1. Protocol for the generation of oligodendrocytes from NS cells. NS cells propagated in NS-A medium plus N2 in the presence of EGF and
FGF2 (A) were cultured in DMEM/F12 plus N2 in the presence of FGF2, PDGF and forskolin for 4 days on polyornithine/laminin coated plastic (B)
before they were induced to differentiate by growth factor withdrawal in the presence of 3,3,5-tri-iodothyronine hormone (T3) and ascorbic acid (AA)
(C,D). After four days, immunostaining for the O4 antigen revealed differentiation into oligodendrocytes (C). The differentiated cultures also
contained GFAP-positive astrocytes and ß-III tubulin/TUJ1-positive neurons (C,D), demonstrating the tripotential differentiation capacity of these
cells.
doi:10.1371/journal.pone.0000298.g001
Oligodendrocytes from NS Cells
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Cell cultures were fixed with 4% PFA for 10 min at room
temperature. After washing in PBS, cells were blocked with 5%
normal goat serum in PBS for 15 min and incubated over night in
1% normal goat serum in PBS with the following primary
antibodies: O4 (mouse IgM; 1:10; Chemicon), Rip (mouse IgG;
1:100; Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA), proteolipid protein (PLP) (rabbit IgG; 1:500;
provided by I.R. Griffiths, Institute of Comparative Medicine,
Glasgow, Scottland), GFAP (rabbit IgG; 1:100; DAKO, Ham-
burg, Germany) and ß-III tubulin (mouse IgG; clone TUJ1; 1:500;
Babco/Covance, Richmond, CA). For intracellular antigens cells
were permeabilized in PBS containing 0.1% Triton X-100.
Antigens were visualized using appropriate fluorochrome-conju-
gated secondary antibodies applied at 1:250 for 1h (goat anti-
mouse IgG-Cy3, goat anti-mouse IgM-Cy3, goat anti-rabbit IgG-
FITC; Jackson Immuno Research; West Baltimore Pike, PA,
USA). DAPI was used for nuclear counterstaining. Labeled cells
were preserved in Vectashield (Vector Laboratories) and analysed
using a Zeiss fluorescence microscope. Negative controls for
antibody specificity were performed by omitting the primary
antibodies. Quantitative analysis was carried out by counting the
number of immunoreactive cells per total number of viable cells as
determined by DAPI staining. Data for each marker are based on
triplicate cultures with $20 randomly chosen high power fields
quantified for each staining.
Cell transplantation, tissue processing and analysis
Cell transplantation into the brain of early postnatal (P2–P3)
myelin-deficient rats (md rats; kindly provided by Ian Duncan,
University of Wisconsin, Madison, USA) was performed as
described [42]. Briefly, cells proliferating in FGF2 and PDGF
for 4 days were harvested with trypsin-EDTA (0.5 mg/ml; Sigma),
followed by treatment with soybean trypsin inhibitor (0.5 mg/ml;
Sigma). They were concentrated in Hanks’ buffered salt solution
and injected into the frontal part of the right and left hemisphere
(200.000 cells/injection in a total volume of 2 ml). Cells were
injected through the skin and meninges using a flame-polished
glass micropipette of 75 mm internal diameter. Fourteen days
following transplantation, the recipients were anesthetized with
a mixture of xylazine (10 mg/kg) and ketamine (80 mg/kg) and
perfused with 4% paraformaldehyde in PBS. The transplanted
brains were post-fixed at 4uC over night, rinsed in PBS,
cryoprotected in 30% sucrose for at least 3 days and cut in an
freezing microtome in the coronal plane. To identify engrafted
oligodendrocytes, 40 mm cryostat sections were subjected to an
Figure 2. Tripotential differentiation of NS cells in vitro and generation of myelinating oligodendrocytes in vivo. (A–E) Quantitative marker
expression and representative immunofluorescence images. The specific culture conditions used to differentiate NS cells resulted in the generation of
oligodendrocytes (,20%) positive for O4 (B), Rip (D) and PLP (E), GFAP-expressing astrocytes (,40%; C–D) and neurons positive for ß-III tubulin/TUJ1
(,10%; C). (F–H) NS cells cultured in N2 medium and proliferated for 4 days in the presence of FGF2, PDGF and forskolin were transplanted into the
brain of 2- to 3-day-old myelin-deficient rats. Two weeks after transplantation, the engrafted cells had formed PLP-positive myelin internodes. Shown
are representative pictures from septum (F) and corpus callosum (G–H). Scale bars B–D, 100 mm; F–H, 20 mm.
doi:10.1371/journal.pone.0000298.g002
Oligodendrocytes from NS Cells
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(n=9) were housed under standard laboratory conditions, and
the surgical procedures were performed in accordance with
institutional guidelines.
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